Trial Outcomes & Findings for Complications, Outcomes and Revisions Following Hiatal Hernia Repair With MIROMESH (NCT NCT03735862)

NCT ID: NCT03735862

Last Updated: 2019-10-01

Results Overview

Patient self-report if they had a revision or other laparoscopic surgery following index procedure.

Recruitment status

COMPLETED

Target enrollment

85 participants

Primary outcome timeframe

6-18 months post index procedure

Results posted on

2019-10-01

Participant Flow

A consecutive cohort of patients who underwent a hiatal hernia repair between 1 Nov 2015 and 1 Mar 2017 at the principle investigator's private practice were identified. Patients were contacted by phone and asked if they were willing to participate. If so they were consented and enrolled.

12 patients declined participation or could not be contacted. These were included in the baseline analysis.

Participant milestones

Participant milestones
Measure
Observations Group
Patients who have undergone a hiatal hernia repair with MIROMESH.
Overall Study
STARTED
73
Overall Study
COMPLETED
73
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Observations Group
n=85 Participants
Patients who have undergone a hiatal hernia repair with MIROMESH. Hepatic derived surgical matrix: Hiatal hernia repair with MIROMESH
Age, Categorical
<=18 years
0 Participants
n=85 Participants
Age, Categorical
Between 18 and 65 years
63 Participants
n=85 Participants
Age, Categorical
>=65 years
22 Participants
n=85 Participants
Age, Continuous
55.9 Years
STANDARD_DEVIATION 12.7 • n=85 Participants
Sex: Female, Male
Female
55 Participants
n=85 Participants
Sex: Female, Male
Male
30 Participants
n=85 Participants
Region of Enrollment
United States
85 Participants
n=85 Participants
GERD-HRQL
27.7 Score
STANDARD_DEVIATION 9.3 • n=85 Participants
Proton Pump Inhibitor Use
Yes
73 Participants
n=85 Participants
Proton Pump Inhibitor Use
No
12 Participants
n=85 Participants

PRIMARY outcome

Timeframe: 6-18 months post index procedure

Population: 12 patients declined participation or could not be contacted.

Patient self-report if they had a revision or other laparoscopic surgery following index procedure.

Outcome measures

Outcome measures
Measure
Observations Group
n=73 Participants
Patients who have undergone a hiatal hernia repair with MIROMESH.
Number of Subjects Who Required a Revision of the Index Surgery.
0 Participants

SECONDARY outcome

Timeframe: 6-18 months post index procedure

Population: 12 patients declined participation or could not be contacted.

The GERD-HRQL score assess the severity of GERD symptomatic and impact on the subjects quality of life. The score is comprised of 10 questions whose answers are summed for the final score. THe score can range from 0 to 50, with 50 being the worst and 0 meaning no impact.

Outcome measures

Outcome measures
Measure
Observations Group
n=73 Participants
Patients who have undergone a hiatal hernia repair with MIROMESH.
Gastroesophageal Reflux Disease Health Related Quality of Life Score (GERD-HRQL)
7.1 Score
Standard Deviation 8.1

SECONDARY outcome

Timeframe: 6-18 months post index procedure

Population: 12 patients declined participation or could not be contacted. One patient did not answer.

Use of PPIs in 3-months prior to follow-up interview

Outcome measures

Outcome measures
Measure
Observations Group
n=72 Participants
Patients who have undergone a hiatal hernia repair with MIROMESH.
Medication Use
Yes
7 Participants
Medication Use
No
65 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 6-18 Months post index procedure

Population: 12 patients declined participation or could not be contacted.

Patients reported their satisfaction with the procedure as "Dissatisfied", "Neutral", or Satisfied.

Outcome measures

Outcome measures
Measure
Observations Group
n=73 Participants
Patients who have undergone a hiatal hernia repair with MIROMESH.
Satisfaction With Procedure
Satisfied
63 Participants
Satisfaction With Procedure
Neutral
6 Participants
Satisfaction With Procedure
Dissatisfied
4 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 6-18 Months post index procedure

Population: 12 patients declined participation or could not be contacted.

Patients were asked to report how likely they would be to recommend this procedure to a friend or loved one with the same condition. Report was based on a scale of 1 (not at all likely) to 10 (very likely).

Outcome measures

Outcome measures
Measure
Observations Group
n=73 Participants
Patients who have undergone a hiatal hernia repair with MIROMESH.
Likelihood to Recommend
<=3
3 Participants
Likelihood to Recommend
>= 4 - <= 7
6 Participants
Likelihood to Recommend
>=8
64 Participants

Adverse Events

Observations Group

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Observations Group
n=73 participants at risk
Patients who have undergone a hiatal hernia repair with MIROMESH.
Surgical and medical procedures
Liver lobe tear
1.4%
1/73 • Number of events 1 • Operative & Peri-Operative, from admission for the surgical event through discharge. (Median length of stay 1 day)
Surgical and medical procedures
Minor bleeding gastric vessels
1.4%
1/73 • Number of events 1 • Operative & Peri-Operative, from admission for the surgical event through discharge. (Median length of stay 1 day)
Surgical and medical procedures
Arterial flutter
1.4%
1/73 • Number of events 1 • Operative & Peri-Operative, from admission for the surgical event through discharge. (Median length of stay 1 day)

Additional Information

Head of Clinical Affairs

Miromatrix

Phone: 952.942-6000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place